Related by context. All words. (Click for frequent words.) 85 Improves Survival 84 Improves Outcomes 84 Shows Promise Against 83 Anti Tumor 83 Survival Benefit 83 Phase 2b Clinical Trial 83 Single Dose 83 Previously Treated 83 Meets Primary Endpoint 82 Patients Treated With 82 Oral Fingolimod 82 Demonstrates Significant 82 Study Evaluating 82 Combination Treatment 82 Pooled Analysis 82 Shows Promising 82 Advanced Melanoma 82 Adjuvant Chemotherapy 82 Shows Efficacy 82 Newly Diagnosed Multiple Myeloma 82 Adjuvant Treatment 82 Antitumor Activity 82 Lowers Risk 81 Preclinical Data 81 Demonstrates Efficacy 81 Relapsing Multiple Sclerosis 81 Proves Effective 81 Hormone Refractory Prostate Cancer 81 Drug Shows Promise 81 Drug Candidate 81 Receives Orphan Drug Designation 81 Completes Patient Enrollment 81 Advanced Prostate Cancer 81 Is Well Tolerated 81 Protease Inhibitor 81 Advanced Colorectal Cancer 81 Anti Tumor Activity 81 Phase 2b Trial 81 Renal Cell Carcinoma 81 Patients Receiving 81 Mouse Model 81 Lung Cancer Drug 81 Osteoporosis Treatment 81 Levels Linked 80 Clinical Trial Results 80 Contrast Agents 80 Gastric Cancer 80 See CLINICAL PHARMACOLOGY 80 Antitumor 80 Hsp# Inhibitor 80 Phase IIb Clinical Trial 80 Novel Oral 80 Severe Sepsis 80 Improved Survival 80 Advanced Renal Cell 80 FDA Approvals 80 Reduces Risk 80 Appears Safe 80 Cholesterol Lowering Drug 80 Myelodysplastic Syndromes 80 HER2 Positive 80 Combo Therapy 80 Hormone Receptor Positive 80 Bone Metastases 80 Long Term Efficacy 80 HCV Protease Inhibitor 80 Slow Progression 80 Tyrosine Kinase Inhibitor 80 Previously Untreated 80 Fungal Infections 79 Adjunctive Therapy 79 Rheumatoid Arthritis Patients 79 Reduced Risk 79 Lung Cancer Survival 79 Elderly Patients 79 Improve Survival 79 Demonstrates Potent 79 FDA Okays 79 Interferon Beta 79 Low Dose 79 Treating Chronic 79 Reduces Pain 79 Study Demonstrates 79 Study Shows Benefits 79 Treated Patients 79 Phase 2a Trial 79 Showed Significant 79 Anticancer Activity 79 Drug Prevents 79 Significantly Improved 79 Initiates Clinical Trial 79 Phase III Clinical Trial 79 Fondaparinux 79 Recombinant Human 79 Advanced Ovarian Cancer 79 Inflammatory Markers 79 Phase 2a Clinical Trial 79 Anticancer Drug 79 Crit Rev 79 Kidney Transplant Patients 79 Investigational Drug 79 Novel Inhibitor 79 Kinase Inhibitor 79 Presents Preclinical Data 79 Randomized Trials 79 Clinical Outcome 79 Nicotine Vaccine 79 Orally Active 79 Pulmonary Arterial Hypertension 79 Significantly Improves 79 Knee Osteoarthritis 79 Meta Analysis 79 Effectively Treats 79 Rheumatoid Arthritis Drug 79 Demonstrates Sustained 79 IND Application 79 Present Preclinical Data 79 Complicated Skin 79 Psoriasis Drug 79 Randomized Double Blind 79 Demonstrates Potential 79 Fracture Risk 79 Investigational Compound 79 Monoclonal Antibody 79 Immunomedics Announces 78 Therapy Improves 78 Kidney Function 78 Patients Suffering 78 Submits NDA 78 Successfully Completes Phase 78 Lupus Drug 78 Progenitor Cells 78 Statistically Significant 78 Tumor Growth 78 Investigational Agent 78 Investigational Treatment 78 Attenuates 78 Inhaled Corticosteroids 78 Proven Effective 78 Relapsed Refractory 78 Clinical Trial Evaluating 78 Multiple Myeloma Patients 78 Beneficial Effects 78 Adjuvant Therapy 78 Significantly Reduces 78 Completes Enrollment 78 Pediatric Patients 78 Treatment Reduces 78 Genes Linked 78 Treatment Naive Patients 78 Metastatic Melanoma 78 Soft Tissue Sarcoma 78 Artery Disease 78 Combination Therapy 78 Trial Evaluating 78 Metastatic Colorectal Cancer 78 Chronic Hepatitis C 78 Patients Undergoing 78 Test Detects 78 Skeletal Muscle 78 Metastatic Prostate Cancer 78 Refractory Hodgkin Lymphoma 78 Phase IIb Trial 78 Epilepsy Drug 78 Phase 2b Study 78 Patients Treated 78 Reduces Mortality 78 Mg Usa 78 Significantly Reduced 78 Hypertensive Patients 78 Breast Cancer Recurrence 78 Postmenopausal Osteoporosis 78 Unfractionated Heparin 78 Pivotal Phase III 78 Prostate Cancer Patients 78 Gene Linked 78 Lung Cancer Trial 78 Prophylactic Treatment 78 Prostate Cancer Vaccine 78 Initiates Clinical 78 Inhibits 78 Initiate Clinical Trial 78 Files IND 78 Antifungal 78 Placebo Controlled Trial 78 Teva Provides Update 78 Drug Fails 78 Preclinical Study 78 Demonstrates Positive 78 Predict Response 78 Hepatitis C Genotype 78 Immune Responses 77 JAK Inhibitor 77 Fewer Side Effects 77 Protease Inhibitors 77 Osteoporosis Drug 77 Rotavirus Vaccine 77 Novel Mechanism 77 Secondary Hyperparathyroidism 77 Initiate Phase 77 Hepatocellular Carcinoma 77 Chemoradiation 77 Shown Effective 77 Well Tolerated 77 Renal Cancer 77 Overactive Bladder 77 Slows Progression 77 Cutaneous T 77 Disease Progression 77 Treatment Resistant 77 Invasive Fungal Infections 77 RNAi Therapeutic 77 Transdermal Patch 77 Monotherapy 77 Immunomodulatory 77 Oral Mucositis 77 Blood Pressure Drug 77 Therapeutic Efficacy 77 Tumor Targeting 77 Protein Linked 77 Demonstrates Statistically Significant 77 Neoadjuvant Chemotherapy 77 Study Showed 77 Resistant Hypertension 77 Diabetic Foot Ulcer 77 Inflammatory Disease 77 Predict Risk 77 HER2 Positive Breast Cancer 77 Antiplatelet 77 Critically Ill Patients 77 Combination REOLYSIN R 77 Castration Resistant Prostate Cancer 77 Drug Combo 77 Randomized Clinical Trials 77 Prospective Randomized 77 Epidermal Growth Factor Receptor 77 Confirms Efficacy 77 Phase III Trial 77 NDA Submission 77 AnaSpec Introduces 77 Oral Calcitonin 77 Subgroup Analysis 77 Advanced Pancreatic Cancer 77 FDA Approves Drug 77 Drug Resistant 77 Novel Antibiotic 77 Protein Involved 77 Anthracycline 77 Newly Diagnosed 77 Breast Cancer Cells 77 II Clinical Trial 77 Dose Ranging Study 77 Node Positive 77 Phase III Trials 77 Data Suggest 77 Enlarged Prostate 77 Diabetic Neuropathy 77 Initiates Phase III 77 Benign Prostatic Hyperplasia 77 Renal Function 77 Plaque Psoriasis 77 Localized Prostate Cancer 77 Novel Therapeutic 77 Demonstrated Significant 77 Polymerase Inhibitor 77 Phase IIa Clinical Trial 77 Guidelines Issued 77 Renal Cell Cancer 77 Successfully Treated 77 Initiates Enrollment 77 Vaginal Gel 77 Controlled Trial 77 Malignant Melanoma 77 Chronic Hepatitis B 77 JAK2 Inhibitor 77 Lowers Blood Pressure 77 Autoimmune Disease 77 Mylan Receives Approval 77 Clinical Efficacy 77 Non Invasive Treatment 76 ACE Inhibitors 76 Treat Anemia 76 Phase 1b Clinical Trial 76 Adenoma 76 FDA Clears 76 Small Molecule 76 Taxane 76 Treatment Experienced 76 Metastatic Renal Cell Carcinoma 76 Antigen Specific 76 Lymphoid 76 Commonly Used 76 HDAC Inhibitor 76 Randomized Study 76 Antiviral Activity 76 Postmenopausal Women 76 Colorectal Cancer Patients 76 Epoetin Alfa 76 Osteoarthritis Patients 76 Randomized Controlled Trials 76 Antiangiogenic 76 Plus Ribavirin 76 Anticoagulant 76 Lupus Nephritis 76 Treatment Naïve 76 Minimally Invasive Treatment 76 Pivotal Study 76 Subtypes 76 Preclinical Models 76 Myeloma Patients 76 Potent Antiviral Activity 76 Disease Modifying 76 Systemic Sclerosis 76 Phase Ib Clinical Trial 76 Dose Escalation 76 Shows Promise 76 Insulin Resistance 76 Patient Enrollment 76 Peginterferon 76 Kinase Inhibitors 76 Obesity Linked 76 Molecular Mechanism 76 Chemotherapy Improves 76 Therapeutic Antibody 76 Prove Effective 76 Pharmacokinetic Study 76 Osteoporosis Drugs 76 Treatment Shows Promise 76 Presents Positive 76 Allogeneic 76 Prolongs Life 76 Efficacy Trial 76 Granted Orphan Drug 76 Smooth Muscle 76 Heart Failure Patients 76 Develop Novel 76 Clinical Trial Data 76 Genes Predict 76 Gastrointestinal Disorders 76 Hepatitis B Vaccine 76 Modulates 76 Vaccine Adjuvant 76 Androgen Deprivation Therapy 76 Insulin Glargine 76 Potentially Fatal 76 Capsules CII 76 Antiviral Drugs 76 Topical Treatment 76 Diabetic Nephropathy 76 Nucleoside 76 Cardiovascular Events 76 Breast Tumors 76 Hematological Malignancies 76 #-# Full Text 76 Immunotherapeutic 76 Sustained Efficacy 76 Relapsed Multiple Myeloma 76 Demonstrate Significant 76 Cell Transplants 76 Receives Approvable Letter 76 Hematological Cancers 76 Immune Cells 76 Atypical Antipsychotic 76 Colorectal Adenomas 76 Therapy Shows Promise 76 FDA Accepts 76 Endometrial Cancer 76 Ovarian Cancer Patients 76 Induces 76 PRN FDA Approves 76 Bosutinib 76 Inflammatory Arthritis 76 Kidney Transplant Recipients 76 Diabetic Patients 76 Non Responders 76 Lung Cancer Patients 76 Desvenlafaxine Succinate 76 First Patient Dosed 76 Acute Ischemic Stroke 75 Mg Uk 75 Vitro Activity 75 Peginterferon Alfa 2a 75 Follicular Lymphoma 75 Novel Compound 75 Cholesterol Drug 75 Pre Cancerous 75 Diagnostic Tests 75 Chronic Lymphocytic Leukemia 75 Systemic Delivery 75 Nymox NX 75 Pivotal Phase 75 Stent Placement 75 Breast Cancer Patients 75 Generic Versions 75 Long Term Outcomes 75 Statin Drugs 75 Fast Track Status 75 Therapy Reduces 75 Unresectable 75 Viral Load 75 Iron Overload 75 Premenopausal Women 75 Obese Patients 75 Expanded Indication 75 Severe Asthma 75 FDA Warns Against 75 Glatiramer Acetate 75 Parathyroid Hormone 75 Initiates Phase II 75 Contrast Agent 75 Efficacious 75 Laryngeal Cancer 75 Aggressive Prostate Cancer 75 Chronic Sinusitis 75 Dendritic Cells 75 Versus Placebo 75 Gene Variant 75 Study Shows Promise 75 Therapeutic Potential 75 Cyclophosphamide 75 Cancer Treatments 75 Hepatocellular 75 Pegylated Interferon 75 Genes Involved 75 J Clin 75 Stomach Cancer 75 Brain Metastases 75 Cardiovascular Disease Risk 75 Skin Lesions 75 Dose Finding 75 Migraine Drug 75 Asthma Treatment 75 Virus Infection 75 Malignant Glioma 75 Tigecycline 75 Cholesterol Lowering 75 Shingles Vaccine 75 Initiate Phase III 75 Hormone Therapy 75 Gout Drug 75 Infected Patients 75 Anemia Drug 75 Vaccine Protects Against 75 Aliskiren 75 Phospholipase A2 75 Autologous Stem Cell Transplantation 75 Antidepressants Linked 75 Hematological 75 Atopic Dermatitis 75 Venous Thromboembolism 75 Randomized Phase II 75 Significant Reduction 75 Smallpox Vaccine 75 Holds Promise 75 Diet Linked 75 Breast Cancers 75 Genes Identified 75 Hypercholesterolemia 75 Improve Outcomes 75 Dose Response 75 Chemotherapeutic Agents 75 Breast Cancer Treatment 75 Protein Synthesis 75 Statin Therapy 75 Mouse Models 75 Treatment Naive 75 Blood Thinner 75 Carotid Stenting 75 Hemodialysis Patients 75 Bazedoxifene 75 Visceral Fat 75 Tumor Response 75 Double Blind Randomized 75 Achieves Primary Endpoint 75 Seasonal Influenza Vaccine 75 Brain Atrophy 75 Novel Treatments 75 Inhaled Nitric Oxide 75 Cyclooxygenase 2 75 Sleep Disturbances 75 Autoimmune Diseases 75 Liver Injury 75 Carboplatin Paclitaxel 75 First Patient Enrolled 75 Nilotinib 75 Prostate Cancer Survival 75 Colorectal Cancer Risk 75 Pneumococcal Vaccine 75 Aurora Kinase 75 5 Fluorouracil 75 Arthritis Drug 75 Antiviral Therapy 75 Prognostic Value 75 J Am Coll 75 Cytotoxic 75 Chronic Inflammation 75 Left Ventricular 75 Immunosuppressant 74 Dry Powder Inhalers 74 Estrogen Therapy 74 Anti Inflammatory 74 Placebo Controlled Study 74 Nebulized 74 Gene Mutation 74 Ovarian Cancers 74 Synthetic Peptide 74 Effective Than 74 Postdoctoral Position 74 Beta Blocker 74 Septic Shock 74 Naive Patients 74 Transdermal Delivery 74 TB Vaccine 74 Cognitive Function 74 Allergic Rhinitis 74 Increased Mortality 74 Non Inferiority 74 Tiotropium 74 Prognostic Factors 74 Partial Onset Seizures 74 Vaccine Candidate 74 ALN HPN 74 Immune Cell 74 Recurrent Breast Cancer 74 Curr Opin 74 Relapsing Remitting Multiple Sclerosis 74 Tyrosine Kinase Inhibitors 74 Helps Predict 74 Menopausal Symptoms 74 Myocardial Ischemia 74 Preterm Labor 74 Muscle Function 74 Advanced Solid Tumors 74 Controlled Study 74 BioElectronics Announces 74 Mimetics 74 Study Casts Doubt 74 Hyperlipidemia 74 Lanthanum Carbonate 74 Increased Risk 74 Muscle Wasting 74 Shows Statistically Significant 74 Gene Variants 74 Thrombotic 74 Treatment Regimen 74 Leukemia Cells 74 Blood Clotting 74 Randomized Double blind 74 Intravenous Immunoglobulin 74 Breast Tumor 74 Breast Cancer Stem Cells 74 Pegylated 74 Increases Risk 74 Targeted Therapies 74 Randomized Phase 74 Dosing Regimen 74 Vildagliptin 74 Hepatitis C Infection 74 Tumor Cell 74 Pivotal Trial 74 Respiratory Virus 74 Prevent Stroke 74 Leukemias 74 Angiogenic 74 Anti Angiogenic 74 Transplant Patients 74 Receptor Agonist 74 NICE Recommends 74 Stem Cell Transplants 74 Mycophenolate Mofetil 74 Symptom Relief 74 Serious Infections 74 Interferon Alpha 74 Melphalan 74 Schizophrenia Treatment 74 Nanoemulsion 74 Effective Treatments 74 Prostate Cancer Treatment 74 Cardiovascular Outcomes 74 Epilepsy Drugs 74 Sirolimus Eluting Stent 74 Vertebral Fractures 74 Milestone Payment 74 Oral Insulin 74 Improves Quality 74 Cholinesterase Inhibitors 74 Anti Inflammatory Drug 74 Tipranavir 74 Fluorouracil 74 Invasive Breast Cancer 74 Radiation Induced 74 Pegylated Liposomal Doxorubicin 74 Drug Eluting 74 Atypical Hemolytic Uremic Syndrome 74 Clinical Study Shows 74 Gastric Ulcers 74 Antipsychotic Drugs 74 Testosterone Patch 74 Bladder Cancer 74 Hormonal Therapy 74 Progressive Multifocal Leukoencephalopathy 74 Gene Variation 74 Surgical Procedures 74 Oral Formulation 74 Fludarabine 74 Pharmacokinetics PK 74 Hospital Acquired Pneumonia 74 R lenalidomide 74 Lung Cancers 74 Metabolic Disorder 74 Radical Prostatectomy 74 Hepatitis C Virus 74 Cholesterol Drugs 74 Renal Impairment 74 ORLive Presents 74 Chemotherapy Induced 74 Confirmatory Phase 74 Fixed Dose 74 Potent Inhibitor 74 Antipsychotic 74 Polymorphisms 74 Medoxomil 74 Less Invasive 74 Investigational Oral 74 Genetic Tests 74 Post Menopausal 74 Bone Fractures 74 Signaling Pathway 74 Diagnostic Criteria 74 Dehydrogenase 74 Left Ventricular Hypertrophy 74 Factor Receptor 74 Lung Tumors 74 First Patient Treated 74 Breast Tissue 74 Paraplatin ® 74 Anthrax Toxin 74 Capecitabine 74 Oral Cavity 74 Hydrochlorothiazide Tablets 74 Liver Failure 74 Angiotensin Converting Enzyme 74 Tissue Engineered 74 Stem Cell Treatment 74 Tezampanel 74 Often Misdiagnosed 74 Fibrinogen 74 Biologic Therapy 74 Anticancer Drugs 74 Collaborators Present 74 Analytical Tool 74 Anticancer Agent 74 Eases Pain 74 Commonly Prescribed 74 Calcium Vitamin D 74 Gastrointestinal Stromal Tumors 74 Interferon Gamma 74 Erectile Dysfunction Drug 74 Inhaled Insulin 74 TNF Blockers 73 Study Evaluates 73 Improve Diagnosis 73 Breast Cancer Metastasis 73 Cervical Dysplasia 73 Inflammatory Response 73 Chronic Renal Failure 73 Cardiac Resynchronization 73 Diabetic Kidney Disease 73 Genes Associated 73 Myelofibrosis 73 Suppresses 73 Receives Positive Opinion 73 Adefovir 73 Significant Improvement 73 Schizophrenia Drug 73 Cancer Cells 73 Announces FDA Clearance 73 Renal Anemia 73 Gets FDA Clearance 73 Uric Acid 73 Cardiac Function 73 Pharmacodynamics 73 Nat Clin Pract 73 Insulin Sensitivity 73 Cognitive Impairment 73 Who Underwent 73 Etanercept 73 Sevelamer 73 Cocaine Addiction 73 Generic Version 73 platform HDL Mimetic 73 Receives Milestone Payment 73 Clinical Evaluation 73 Blood Pressure Drugs 73 Hepatic Encephalopathy 73 Eur J 73 Prostate Tumors 73 Vaccine Shows Promise 73 Anti Clotting Drug 73 Viral Suppression 73 Radiation Dose 73 Blood Cancers 73 Decitabine 73 Recurrent Prostate Cancer 73 Helps Identify 73 Chronic Myeloid Leukemia 73 Therapeutic Vaccine 73 Phase III Clinical Trials 73 Fulvestrant 73 Chemotherapy Regimen 73 Genetic Variation 73 Detect Cancer 73 Suicidality 73 Colorectal Cancers 73 Dose Ranging 73 Bipolar Mania 73 Inflammatory Diseases 73 Randomized Clinical Trial 73 Cannabinoid 73 Experimental Vaccine 73 Maven Semantic 73 Initiates Clinical Trials 73 CYT# potent vascular disrupting 73 Receptor Antagonist 73 Cardiotoxicity 73 Platinol ® 73 Elevated Levels 73 Interferon Alfa 73 Prostate Cancers 73 Maleate 73 Autoimmune Disorders 73 Virus Linked 73 Antibody Drug Conjugate 73 Boosts Survival 73 Solid Tumors 73 Diuretic 73 Estrogen Receptor 73 Develops Novel 73 FDA APPROVES 73 Bivalirudin 73 Recommends Approval 73 Oral Spray 73 Valproic Acid 73 Regenerative Cells 73 Reperfusion Injury 73 TO AVOID PREGNANCY WHILE 73 Contrast Enhanced 73 Double Blind Placebo 73 Zorbtive TM 73 Significant Improvements 73 Premature Infants 73 RNAi Therapeutics 73 Tumor Necrosis Factor 73 Antiplatelet Therapy 73 Telaprevir VX 73 Neuroendocrine Tumors 73 Higher Doses 73 Spectrum Pharmaceuticals Announces 73 Coronary Arteries 73 Replacement Therapy 73 Reports Preclinical Data 73 Could Prevent 73 Venous Thrombosis 73 Study Shows Significant 73 Receives Orphan Drug 73 Receptor Antagonists 73 Orthop Surg 73 Osteoarthritis Pain 73 Lymphocytic 73 Cancer Incidence Mortality 73 Interferon beta 1a 73 Hematopoietic 73 Pivotal Clinical Trial 73 Dasatinib 73 Unstable Angina 73 IND Filing 73 Early Diagnosis 73 Treatment Naïve Patients 73 Thyroid Hormone 73 Systematic Review 73 Initiates Phase 73 Urinary Incontinence 73 Peripheral Blood 73 CYP#A# substrate 73 Carcinomas 73 Antipsychotic Medications 73 FDA Panel Recommends 73 Genetic Mutation 73 Chemotherapeutic 73 Renal Artery 73 Molecular Diagnostic Test 73 Heartburn Drugs 73 Rheumatoid 73 Gene Mutations 73 Liver Metastases 73 Preclinical Efficacy 73 Long Term Survival 73 Comorbidities 73 Intravitreal 73 Breast Density 73 Calcium Supplements 73 Antibiotic Treatment 73 Potent Anti 73 Peripheral Arterial 73 Chronic Myelogenous Leukemia 73 Presents Preclinical 73 Pregnancy Linked 73 Atypical Antipsychotics 73 Adverse Effects 73 Avian Flu Vaccine 73 Diabetic Neuropathic Pain 73 Excretion 73 Neoadjuvant 73 Myocardial Perfusion Imaging 73 Premature Aging 73 Peginterferon alfa 2b 73 Endovascular Treatment 73 CYP#A# CYP#D# 73 Bare Metal Stents 73 Total Knee Arthroplasty 73 Circulating Tumor Cells 73 Mesothelioma Treatment 73 Tumor Suppressor Gene 73 Sustained Reduction 73 Posaconazole 73 Respiratory Distress 73 lexidronam injection 73 Strongly Linked 73 Genetic Marker 73 Sustained Release 73 Fibromyalgia Pain 72 Tumor Suppressor 72 Am J Clin 72 Being Studied 72 Adenomas 72 Endothelial Cells 72 Cinacalcet 72 Antibiotic Resistant 72 TNF Tumor Necrosis Factor 72 Cholesterol Levels 72 Adipose Derived Stem Cells 72 Percutaneous Tibial Nerve Stimulation 72 Antiepileptic Drug 72 Immunosuppression 72 Ischemic Stroke 72 Soy Isoflavones 72 Intravenous Formulation 72 Adenoviral 72 Complete Remission 72 Study Compares 72 Study Reinforces 72 Hormone Receptor 72 Poster Presentations 72 Testosterone Gel 72 Hernia Repair 72 Asthma Symptoms 72 J Am Acad 72 Refractory Angina 72 Abiraterone Acetate 72 Antithrombin 72 Lipid Lowering 72 Genetic Markers 72 Novel Protein 72 Proteasome 72 Therapeutic Vaccines 72 Cellular Immunotherapy 72 Carotid Endarterectomy 72 Help Detect 72 Could Predict 72 Regimens 72 MEK Inhibitor 72 Bare Metal Stent 72 Patients Enrolled 72 Male Contraceptive 72 vapreotide acetate 72 R Saizen R 72 Neovascular Age Related Macular 72 Bone Marrow Cells 72 Cancer Stem Cells 72 Anticancer Agents 72 Anti Angiogenesis 72 REMINDER ORLive Presents 72 IIa Clinical Trial 72 Pharmacologic 72 Intravesical 72 Helps Prevent 72 Antibiotic Use 72 Antidepressant Drug 72 Microalbuminuria 72 Androgen Independent 72 Lung Cancer Risk 72 Migraine Treatment 72 Hedgehog Pathway 72 Bone Mineral Density 72 Hepatitis B Virus 72 Phase III Pivotal 72 Glufosfamide 72 Bacterial Infection 72 Multicenter Trial 72 Lowers Cholesterol 72 Cell Proliferation 72 Smoking Linked 72 Poorly Controlled 72 Radiofrequency Ablation 72 Antipsychotic Drug 72 Partial Nephrectomy 72 Lung Injury 72 Epratuzumab 72 Phase III Pivotal Trial 72 Ebola Vaccine 72 Cancer Recurrence 72 Helps Relieve 72 Pain Relievers 72 Guidelines Recommend 72 Ischemic 72 Medullary Thyroid Cancer 72 Tumor Progression 72 Beta Blockers 72 ISTODAX ® 72 Drug Coated Stents 72 Oxidative Stress 72 Files Investigational 72 Tablet Formulation 72 ST Segment Elevation 72 NMDA Receptor 72 Eluting Stent 72 metastatic malignant 72 Camptosar ® 72 Vascular Inflammation 72 Prognostic Significance 72 Cancer Biomarkers 72 Signaling Pathways 72 Antidepressant Use 72 Oral Anticoagulant 72 Efficacy Results 72 Stent Restenosis 72 Preterm Delivery 72 essential thrombocythemia ET 72 Sex Hormones 72 Catheter Associated 72 Endothelial Function 72 Fluticasone 72 Emerging Therapies 72 Intracranial Aneurysms 72 Genetic Variant 72 Endocrinol 72 Clostridium difficile Infection 72 J Allergy Clin 72 Thromboembolism 72 Endovascular Repair 72 Impairs 72 ST Elevation Myocardial 72 Solid Malignancies 72 Panic Disorder 72 Commence Phase 72 Viral Infections 72 Liver Toxicity 72 Begins Dosing 72 Fluconazole 72 erlotinib Tarceva ® 72 Diabetic Foot Ulcers 72 B Cell Lymphoma 72 Remission Maintenance 72 Rectal Cancer 72 Treatment Approaches 72 Adult Stem Cell Therapy 72 Anticancer Compound 72 adalimumab Humira 72 Extended Release 72 Novel Method 72 Cognitive Deficits 72 Conjugated 72 Bevacizumab 72 Liver Tumors 72 Cypher Sirolimus 72 Metastatic Cancer 72 Therapeutic Antibodies 72 Romidepsin 72 Predict Dementia 72 Treat Heart Failure 72 Newly Diagnosed Breast Cancer 72 SPRYCEL ® 72 Sinus Infections 72 Primary Hypercholesterolemia 72 Chronic Lymphocytic Leukemia CLL 72 Allergic Reactions 72 Initiates Dosing 72 Myelodysplastic Syndrome MDS 72 Initiates Phase 2b 72 Oral Presentations 72 Irinotecan 72 Iron Deficiency 72 Genital Warts 72 Lymphoma Patients 72 Brain Scans 72 Obstet Gynecol 72 Vitamin D Linked 72 Adjuvant Breast Cancer 72 Hormone Replacement